Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover

Given that adverse remodeling is the leading cause of heart failure and death in the USA, there is an urgent unmet need to develop new methods in dealing with this devastating disease. Here we evaluated the efficacy of a short-course glucagon-like peptide-1 receptor agonist therapy—specifically 2-qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Germano, Juliana de F., Huang, Chengqun, Sin, Jon, Song, Yang, Tucker, Kyle C., Taylor, David J. R., Saadaeijahromi, Hannaneh, Stotland, Aleksandr, Piplani, Honit, Gottlieb, Roberta A., Mentzer, Robert M., Andres, Allen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237417/
https://www.ncbi.nlm.nih.gov/pubmed/32427925
http://dx.doi.org/10.1038/s41598-020-64924-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237417/
https://www.ncbi.nlm.nih.gov/pubmed/32427925
http://dx.doi.org/10.1038/s41598-020-64924-2

Ejemplares similares